The results indicated that astrocyte-specific molecules were enriched in AD compared to MCI, and HSPA1A, NPEPPS, and PTGFRN can be applied to monitor the progression of MCI to AD (Muraoka et al., 2020b). The gene discussed is NPEPPS; the disease is Alzheimer disease.